Myocardial Injury and Myocarditis in SARS-CoV-2 Patients

1. Basu-Ray I, Almaddah NK, Adeboye A, Soos MP. Cardiac Manifestations Of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2020.Search in Google Scholar

2. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247-250.10.1016/j.dsx.2020.03.013Search in Google Scholar

3. Hulot JS. COVID-19 in patients with cardiovascular diseases. Arch Cardiovasc Dis. 2020;113:225-226.10.1016/j.acvd.2020.03.009Search in Google Scholar

4. Zhu H, Rhee JW, Cheng P, et al. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response. Curr Cardiol Rep. 2020;22:32.10.1007/s11886-020-01292-3Search in Google Scholar

5. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141:1648-1655.10.1161/CIRCULATIONAHA.120.046941Search in Google Scholar

6. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-260.10.1038/s41569-020-0360-5Search in Google Scholar

7. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-422.10.1016/S2213-2600(20)30076-XSearch in Google Scholar

8. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116:1097-1100.10.1093/cvr/cvaa078718450732227090Search in Google Scholar

9. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371.10.1016/j.jacc.2020.03.031719885632201335Search in Google Scholar

10. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies. JACC Basic Transl Sci. 2020;5:518-536.10.1016/j.jacbts.2020.04.002715139432292848Search in Google Scholar

11. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666-1687.10.1093/cvr/cvaa106719762732352535Search in Google Scholar

12. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390-391.10.1016/j.pcad.2020.03.001Search in Google Scholar

13. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J. 2020.10.1093/eurheartj/ehaa190Search in Google Scholar

14. Maisch B. SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS? SARS-CoV-2 als mögliche Ursache für Myokarditis und Herzinsuffizienz. Ist es das Virus, Hyperinflammation oder MODS? Herz. 2020;45:321-322.10.1007/s00059-020-04925-zSearch in Google Scholar

15. Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116-121.10.1016/j.ijcard.2020.03.087Search in Google Scholar

16. Sala S, Peretto G, Gramegna M, et al. Acute Myocarditis Presenting as a Reverse Takotsubo Syndrome in a Patient With SARS-CoV-2 Respiratory Infection. Eur Heart J. 2020;41:1861-1862.10.1093/eurheartj/ehaa286Search in Google Scholar

17. Kochi AN, Tagliari AP, Forleo GB, et al. Cardiac and arrhythmic complications in patients with COVID-19. Cardiovasc Electrophysiol. 2020;31:1003-1008.10.1111/jce.14479Search in Google Scholar

18. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45:230-232.10.1007/s00059-020-04909-zSearch in Google Scholar

19. Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020;253:117723.10.1016/j.lfs.2020.117723Search in Google Scholar

20. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.10.1016/S0140-6736(20)30183-5Search in Google Scholar

21. Ozieranski K, Tyminska A, Caforio ALP. Clinically suspected myocarditis in the course of coronavirus infection. Eur Heart J. 2020;41:2118-2119.10.1093/eurheartj/ehaa353719753632338758Search in Google Scholar

22. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-625.10.1111/j.1365-2362.2009.02153.x716376619453650Search in Google Scholar

23. Augoustides JG. Cardiovascular Consequences and Considerations of Coronavirus Infection – Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis. J Cardiothorac Vasc Anesth. 2020;S1053-0770(20)30315-3.Search in Google Scholar

24. Xiong TY, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41:1798-1800.10.1093/eurheartj/ehaa231745451332186331Search in Google Scholar